CDP Q1 2026 Earnings EPS Beats Estimates by 201 Shares Gain 148 Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress AMTB Q1 2026 Earnings EPS Slightly Below Estimates Shares Edge Higher DCH Q1 2026 Earnings Massive EPS Surprise Propels Stock Higher STAG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gains